注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Seer Inc是一家生命科学公司。该公司致力于开发变革性产品。该公司的初始产品Proteograph产品套件利用工程纳米颗粒(NP)技术提供对蛋白质组的大规模访问。Proteograph产品套件是一项集成解决方案,由耗材、自动化仪器和软件组成。它的方法基于工程化的NP,能够在蛋白质组的动态范围内对完整蛋白质进行无偏采样,在蛋白质变体以及蛋白质-蛋白质相互作用(PPI)水平上捕获大量分子信息。它专注于与蛋白质组学和基因组学市场的客户一起采用Proteograph。该公司最初专注于Proteograph产品套件的研究应用,并且正在销售和推广Proteograph仅供研究使用 (RUO),从而消除对其他公正方法所需复杂工作流程的需求。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
David B. Singer | 58 | 2017 | Independent Director |
David L. Hallal | 56 | 2018 | Lead Independent Director |
Mark B. McClellan | 59 | - | Member of Scientific Advisory Board |
Vivek Farias | - | - | Member of Scientific Advisory Board |
Steven A. Carr | - | - | Member of Scientific Advisory Board |
Charles R. Cantor | 80 | - | Member of Scientific Advisory Board |
Luis Alberto Diaz | 52 | - | Member of Scientific & Clinical Advisory Board |
Omid C. Farokhzad | 54 | 2017 | Founder, CEO, & Chair of the Board of Directors |
Robert S. Langer | 74 | 2017 | Co-Chairman of Scientific Advisory Board & Director |
Rachel E. Haurwitz | 37 | 2021 | Independent Director |
Joshua Coon | - | 2023 | Member of Scientific & Clinical Advisory Board |
Bruce Wilcox | - | 2023 | Member of Scientific Advisory Board |
Meeta Gulyani | 55 | 2021 | Independent Director |
Terrance G. McGuire | 68 | 2017 | Independent Director |
Dipchand V. Nishar | 55 | 2021 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核